Press Releases
Press Release
Aparito and TruLab Partner to Improve Rare Disease Studies
July 31 2023, 09:00 EST Aparito and TruLab, two companies focused on improving rare disease studies, have formed a partnership to improve the efficiency and experience of clinical trials. TruLab's tec...
Press Release
PHA UK join Welsh health tech startup's Patient Group Accelerator Programme
Aparito are delighted to announce our latest Patient Group Accelerator Programme partnership with PHA UK and welcome them into Aparito’s Patient Group Accelerator Programme to develop endpoints for pa...
Press Release
Aparito Win Daily Post Business Award for Innovation and Technology
Aparito, a Wrexham-based MedTech company, won the Innovation and Technology Award at the 2021 Daily Post Business Awards for their Atom5TM clinical trial software platform. The award recognises the tr...
Press Release
Aparito selected for Fast-track Programme to Barcelona-Catalonia Life Science Hub
Thanks to Catalonia Trade & Investment, Aparito is one of 10 biotech and life sciences companies from the UK to be selected for the Fast-Track Programme to Barcelona-Catalonia Life Science Hub as part...
Press Release
Time to See the Difference: Video Capture for Patient-Centered Clinical Trials
Authored by Aparito and Alexion, AstraZeneca Rare Disease, "Time to See the Difference: Video Capture for Patient-Centered Clinical Trials" outlines FDA and EMA approved drugs that utilised video-base...
Press Release
National Drug Trial to Prevent Deaths after COVID Patients Leave Hospital
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with Covid-19. The clinical trial named ‘HEAL-COVID’ - also aims to cut the number o...
Press Release
Aparito partnership with the University of Birmingham
Aparito (a med-tech company based in Wrexham UK and Leiden Netherlands) and the University of Birmingham, UK, today announce their partnership. This partnership will see the configuration of Aparito’s...
Press Release
DZNE and Aparito develop mobile app to assess ataxia symptoms at home
15 January 2021 , Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE, the German Centre for Neurodegenerative Diseases) and Aparito (a Welsh and Dutch based med-tech company) today announ...